Texas two-step bankruptcy

Cancer Victims Support Sen. Richard Blumenthal in Urging Johnson & Johnson to Accept Responsibility

Retrieved on: 
Monday, October 30, 2023

At a recent news conference, Sen. Richard Blumenthal, D-Conn., flanked by ovarian cancer victims Lynn Skoda and Joan Kiley, sharply criticized Johnson & Johnson (NYSE: JNJ) for its role in the spread of cancer through its talcum powder products.

Key Points: 
  • At a recent news conference, Sen. Richard Blumenthal, D-Conn., flanked by ovarian cancer victims Lynn Skoda and Joan Kiley, sharply criticized Johnson & Johnson (NYSE: JNJ) for its role in the spread of cancer through its talcum powder products.
  • Ms. Kiley conveyed her emotional story, holding a photograph of her loved ones taken during her chemotherapy for ovarian cancer.
  • Her account emphasized the broad impact of Johnson & Johnson's alleged negligence, highlighting the collective suffering of many families.
  • Blumenthal is part of a growing chorus of concerned lawmakers challenging Johnson & Johnson to rise to the occasion,” said Mr. Birchfield.

Possible Third J&J Bankruptcy Attempt Amplifies Concerns over Corporate Abuse of Courts

Retrieved on: 
Tuesday, October 24, 2023

"J&J's corporate leadership seems determined to keep pushing this strategy, and as advocates for these women we will continue to push back."

Key Points: 
  • "J&J's corporate leadership seems determined to keep pushing this strategy, and as advocates for these women we will continue to push back."
  • During the past year, the U.S. Bankruptcy Court in New Jersey and the Third U.S.
  • Circuit Court of Appeals has ruled J&J's ploy does not meet the standards for a good faith bankruptcy, in large part because the multibillion-dollar company is not in "financial distress."
  • Attorneys for the plaintiffs believe that under bankruptcy laws those victims would receive far less compensation than through civil trials or settlement negotiations outside of the bankruptcy system.

The Official Committee of Talc Claimants Applauds Decision to Dismiss LTL Management Second Bankruptcy Attempt

Retrieved on: 
Friday, July 28, 2023

NEW YORK, July 28, 2023 /PRNewswire/ -- The Official Committee of Talc Claimants (the "Committee"), which has been tirelessly pursuing justice for its constituency of talc victims injury by Johnson & Johnson's ("J&J's") talc products, is pleased with the court's decision to dismiss the second bankruptcy attempt.

Key Points: 
  • NEW YORK, July 28, 2023 /PRNewswire/ -- The Official Committee of Talc Claimants (the "Committee"), which has been tirelessly pursuing justice for its constituency of talc victims injury by Johnson & Johnson's ("J&J's") talc products, is pleased with the court's decision to dismiss the second bankruptcy attempt.
  • We believe the decision of the Honorable Chief Judge Kaplan was thoughtful, well-reasoned, and well-supported by the facts and law.
  • The Committee has consistently contended the tort system is the rightful place for these claims to be resolved.
  • Untold numbers  of cancer victims have died while Johnson & Johnson attempted to manipulate the bankruptcy system to limit its liabilities," added Molton.

The Official Committee of Talc Claimants Applauds Decision to Dismiss LTL Management Second Bankruptcy Attempt

Retrieved on: 
Friday, July 28, 2023

NEW YORK, July 28, 2023 /PRNewswire/ -- The Official Committee of Talc Claimants (the "Committee"), which has been tirelessly pursuing justice for its constituency of talc victims' injury by Johnson & Johnson's ("J&J's") talc products, is pleased with the court's decision to dismiss the second bankruptcy attempt.

Key Points: 
  • NEW YORK, July 28, 2023 /PRNewswire/ -- The Official Committee of Talc Claimants (the "Committee"), which has been tirelessly pursuing justice for its constituency of talc victims' injury by Johnson & Johnson's ("J&J's") talc products, is pleased with the court's decision to dismiss the second bankruptcy attempt.
  • We believe the decision of the Honorable Chief Judge Kaplan was thoughtful, well-reasoned, and well-supported by the facts and law.
  • The Committee has consistently contended the tort system is the rightful place for these claims to be resolved.
  • Untold numbers of cancer victims have died while Johnson & Johnson attempted to manipulate the bankruptcy system to limit its liabilities," added Molton.

Levy Konigsberg Sues Kenvue in 116 Mesothelioma Johnson's Baby Powder Lawsuits

Retrieved on: 
Thursday, June 15, 2023

NEW YORK, June 15, 2023 /PRNewswire/ -- Levy Konigsberg, a leading national law firm representing victims of corporate misconduct, has sued J&J's new consumer health spin-off, Kenvue, in 116 Johnson's Baby Powder mesothelioma cases.  Kenvue was initially listed in May in the New York Stock Exchange (KVUE) as part of an initial public offering (IPO) at a $22 per share price.  The stock price has since risen to over $25 per share, giving the new consumer health company a market cap of over 48 billion.

Key Points: 
  • Levy Konigsberg has filed 116 mesothelioma cases against J&J's new consumer health spin-off, Kenvue (NYSE: KVUE)
    NEW YORK, June 15, 2023 /PRNewswire/ -- Levy Konigsberg, a leading national law firm representing victims of corporate misconduct, has sued J&J's new consumer health spin-off, Kenvue, in 116 Johnson's Baby Powder mesothelioma cases.
  • Kenvue owns the Johnson's Baby product lines, which include well-known products such as Johnson's Baby Powder and Johnson's Baby Shampoo.
  • Kenvue is now profiting from the Johnson's Baby Powder business and is liable, along with Johnson & Johnson, under well-established New Jersey law."
  • Levy Konigsberg LLP has been representing victims of mesothelioma in civil lawsuits since 1985.

Levy Konigsberg Files Motion to Consolidate 22 Talc Mesothelioma Lawsuits for Trial Against Johnson & Johnson

Retrieved on: 
Tuesday, April 25, 2023

NEW YORK, April 24, 2023 /PRNewswire/ -- Levy Konigsberg, a leading national law firm representing victims of corporate misconduct, has filed a motion to consolidate for trial the cases of 22 people diagnosed with mesothelioma caused by asbestos in Johnson's Baby Powder. The motion was filed in the Superior Court in Middlesex County, New Jersey, and seeks to have a jury evaluate the evidence of Johnson & Johnson's (J&J) egregious corporate wrongdoing.

Key Points: 
  • Levy Konigsberg files motion in New Jersey state court to consolidate for trial 22 mesothelioma cases caused by asbestos in Johnson's Baby Powder.
  • NEW YORK, April 24, 2023 /PRNewswire/ -- Levy Konigsberg, a leading national law firm representing victims of corporate misconduct, has filed a motion to consolidate for trial the cases of 22 people diagnosed with mesothelioma caused by asbestos in Johnson's Baby Powder.
  • The ruling allows these 22 mesothelioma cases, and other filed against J&J, to proceed toward long-awaited jury trials.
  • Levy Konigsberg LLP has been representing victims of mesothelioma in civil lawsuits since 1985.

Aearo and 3M Maintain Focus on Resolving Combat Arms Litigation

Retrieved on: 
Friday, February 3, 2023

Aearo and 3M intend to continue to engage in mediation discussions toward a global resolution working with all parties, the mediators, and the courts.

Key Points: 
  • Aearo and 3M intend to continue to engage in mediation discussions toward a global resolution working with all parties, the mediators, and the courts.
  • The motion to dismiss has no immediate impact on these ongoing efforts to resolve the litigation.
  • Aearo and 3M will continue to vigorously defend their position regarding this motion, in the multi-district litigation, and in pursuing their appeals.
  • We are proud of our commitment to keeping our military safe through the supply of 3M products and we will continue to defend the product at issue in this litigation.

Federal Appellate Court Rejects Controversial J&J Ploy to Dodge Talc Cancer Lawsuits

Retrieved on: 
Tuesday, January 31, 2023

PHILADELPHIA, Jan. 30, 2023 /PRNewswire/ -- Trial lawyers with the Nachawati Law Group praised a ruling by the U.S. Court of Appeals for the Third Circuit rejecting Johnson & Johnson's (NYSE: JNJ) use of a controversial bankruptcy ploy to shed more than 38,000 lawsuits filed by women who developed ovarian cancer after using J&J's talc-based products.

Key Points: 
  • The Nachawati Law Group represents numerous women who have been diagnosed with ovarian cancer after years of using Johnson's Baby Powder and other talc products produced by the company.
  • "Our clients are grateful that the appellate court saw through this cynical attempt by J&J to avoid responsibility," said Mr. Nachawati.
  • In 2021, J&J transferred the lawsuits and jury verdicts to a shell company known as LTL Management.
  • 1 nationally in products liability filings in federal court over the past three years, according to Lex Machina.

Federal Appellate Court Rejects Controversial J&J Ploy to Dodge Talc Cancer Lawsuits

Retrieved on: 
Monday, January 30, 2023

PHILADELPHIA, Jan. 30, 2023 /PRNewswire/ -- Trial lawyers with the Nachawati Law Group praised a ruling by the U.S. Court of Appeals for the Third Circuit rejecting Johnson & Johnson's (NYSE: JNJ) use of a controversial bankruptcy ploy to shed more than 38,000 lawsuits filed by women who developed ovarian cancer after using J&J's talc-based products.

Key Points: 
  • The Nachawati Law Group represents numerous women who have been diagnosed with ovarian cancer after years of using Johnson's Baby Powder and other talc products produced by the company.
  • "Our clients are grateful that the appellate court saw through this cynical attempt by J&J to avoid responsibility," said Mr. Nachawati.
  • "We will press forward to ensure that jury trials resume, and these women can have the opportunity for justice they deserve."
  • In 2021, J&J transferred the lawsuits and jury verdicts to a shell company known as LTL Management.

Third Circuit Ruling Reopens Courthouse Doors for Talc-Asbestos Claims

Retrieved on: 
Monday, January 30, 2023

PHILADELPHIA, Jan. 30, 2023 /PRNewswire/ -- Thousands of women and family members whose talc-related legal cases against health care giant Johnson & Johnson (NYSE: JNJ) have been on hold for a year can move forward now, following a ruling today by the U.S. Court of Appeals for the Third Circuit.

Key Points: 
  • This decision will result in the lifting of an injunctive stay that had put on hold 38,000 legal cases while the health care giant pursued a strategy centered around bankruptcy.
  • Evidence produced during years of trials shows the company repeatedly denied or covered up the scientific evidence of the association of the product to ovarian cancer.
  • While today's ruling was critical of the strategy, the court remanded the case to federal bankruptcy court in New Jersey for dismissal.
  • Earlier this year, Johnson & Johnson announced a halt to future sales and distribution of talc-based products worldwide, citing the legal claims brought by ovarian cancer and mesothelioma victims.